US2012107241A1PendingUtilityA1

Particles for Inhalation Having Sustained Release Properties

64
Assignee: EDWARDS DAVID APriority: May 24, 1996Filed: Aug 29, 2011Published: May 3, 2012
Est. expiryMay 24, 2016(expired)· nominal 20-yr term from priority
A61K 9/1694A61K 38/28A61K 31/135A61K 47/24A61K 9/1658A61K 31/566A61K 47/12A61K 9/1623A61K 31/137A61K 9/0075A61K 9/1641A61K 9/1647A61K 9/16A61K 47/6927A61K 38/38A61K 9/1617A61K 9/0073
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylactic or diagnostic agent or any combination thereof in association with a charged lipid, wherein the charged lipid has an overall net charge which is opposite to that of the agent upon association with the agent. Release of the agent from the administered particles occurs in a sustained fashion.

Claims

exact text as granted — not AI-modified
1 . Biocompatible particles for delivery of a therapeutic, prophylactic or diagnostic agent to the pulmonary system; wherein the particles have a tap density of less than 0.4 g/cm 3 , the particle size is about 5-10 μm, and the particles have a mean aerodynamic diameter between about 1 μm and about 5 μm.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.